Analytical Lens: Exploring Maravai LifeSciences Holdings Inc (MRVI)’s Financial Story Through Ratios

In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The closing price of Maravai LifeSciences Holdings Inc (NASDAQ: MRVI) was $5.62 for the day, up 6.24% from the previous closing price of $5.29. In other words, the price has increased by $6.24 from its previous closing price. On the day, 3.32 million shares were traded. MRVI stock price reached its highest trading level at $5.85 during the session, while it also had its lowest trading level at $4.96.

Ratios:

Our analysis of MRVI’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 9.94 and its Current Ratio is at 10.74. In the meantime, Its Debt-to-Equity ratio is 1.63 whereas as Long-Term Debt/Eq ratio is at 1.59.

On August 28, 2024, Wells Fargo started tracking the stock assigning a Overweight rating and target price of $10.Wells Fargo initiated its Overweight rating on August 28, 2024, with a $10 target price.

Insider Transactions:

Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Nov 12 ’24 when DeFord John A bought 17,500 shares for $5.75 per share. The transaction valued at 100,625 led to the insider holds 70,046 shares of the business.

HULL CARL bought 175,000 shares of MRVI for $987,000 on Nov 11 ’24. The insider now owns 175,000 shares after completing the transaction at $5.64 per share. On May 28 ’24, another insider, GTCR INVESTMENT XI LLC, who serves as the Director of the company, sold 9,940,974 shares for $9.81 each. As a result, the insider received 97,570,660 and left with 20,150,005 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MRVI now has a Market Capitalization of 1419207296 and an Enterprise Value of 1100333440. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.12 while its Price-to-Book (P/B) ratio in mrq is 2.31. Its current Enterprise Value per Revenue stands at 3.973 whereas that against EBITDA is 1062.098.

Stock Price History:

Over the past 52 weeks, MRVI has reached a high of $11.56, while it has fallen to a 52-week low of $4.28. The 50-Day Moving Average of the stock is -22.18%, while the 200-Day Moving Average is calculated to be -30.49%.

Shares Statistics:

MRVI traded an average of 1.78M shares per day over the past three months and 2211710 shares per day over the past ten days. A total of 132.23M shares are outstanding, with a floating share count of 117.54M. Insiders hold about 17.14% of the company’s shares, while institutions hold 89.76% stake in the company. Shares short for MRVI as of 1731628800 were 6962636 with a Short Ratio of 4.61, compared to 1728950400 on 8968088. Therefore, it implies a Short% of Shares Outstanding of 6962636 and a Short% of Float of 5.8500000000000005.

Most Popular